Access to Medicines Want to Boost Regional Vaccine Manufacturing? Let Countries Prioritize, Ensure Tech Transfer Newsletter Edition #56 [Treaty Talks] By Priti Patnaik / 22 Nov 2023
Access to Medicines A Little Fairer is Not Good Enough: Why ABS Will NOT Ensure Equity [GUEST ESSAY] Newsletter Edition #55 [Treaty Talks] By Priti Patnaik / 15 Nov 2023
Pricing Johnson & Johnson’s Patenting & Pricing Strategy for TB Medicine Bedaquiline: A Cautionary Tale for New TB Medicines [GUEST ESSAY] Newsletter Edition #200 [The Curated Primer] By Priti Patnaik / 6 Oct 2023
![A Little Fairer is Not Good Enough: Why ABS Will NOT Ensure Equity [GUEST ESSAY]](https://storage.ghost.io/c/3e/27/3e275aa8-3271-4edb-ac7b-04dcacf8a053/content/images/size/w30/substack-post-media-s3-amazonaws-com/public/images/c194a843-3625-4993-b6de-3b4b4e4c5f51_5616x3744.jpg)
![A Little Fairer is Not Good Enough: Why ABS Will NOT Ensure Equity [GUEST ESSAY]](https://storage.ghost.io/c/3e/27/3e275aa8-3271-4edb-ac7b-04dcacf8a053/content/images/size/w960/format/webp/substack-post-media-s3-amazonaws-com/public/images/c194a843-3625-4993-b6de-3b4b4e4c5f51_5616x3744.jpg)
![Johnson & Johnson’s Patenting & Pricing Strategy for TB Medicine Bedaquiline: A Cautionary Tale for New TB Medicines [GUEST ESSAY]](https://storage.ghost.io/c/3e/27/3e275aa8-3271-4edb-ac7b-04dcacf8a053/content/images/size/w960/format/webp/substack-post-media-s3-amazonaws-com/public/images/f36f3802-bd56-4ad0-bc72-fe2fe0929e3d_4032x3024.jpg)